Rhinovirus (RV) is the viral agent most frequently associated with RSV (18.1%-26.1% of AB cases with RSV in children ≤2 years of age) [ 31, 32].
Another example is RSV connection with cytoskeleton where actin crosslinking protein filamin A was observed to colocalise with RSV in host cells using a yeast two-hybrid screen.
RFI-641 inhibited RSV in vitro and in vivo models.
2017 will mark the 60th anniversary since the first isolation of RSV in children.
The detection and quantity of RSV in respiratory specimens was associated with younger age, but not with gender or hospitalization.
HEK293 cells were infected with RVS, and the antiviral activity of polysaccharide extract against RSV in host cells was tested.
The study assesses the cost-effectiveness of palivizumab versus no prophylaxis in infants at high risk of hospitalisation with RSV in the United Kingdom (UK).
Chronic Biologics given intramuscularly Palivizumab†, Synagis® mAb Prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (RSV) in children at high risk of RSV disease.
Together, experimental results encourage promotion of this recombinant SV construct as a vaccine candidate for the prevention of RSV in humans.
Conclusions: These real-time RT-PCR assays provide a rapid, specific, and highly sensitive alternative for detecting, quantifying, and subtyping RSV in clinical specimens.
